Haohua Yao

Dr. Haohua Yao


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2025 in Translational Andrology and Urology
Verified
Journal Article
Open access
PDF file
HLHaishan Lin
Haishan Lin
SLShurong Li
Shurong Li
YCYuhang Chen
Yuhang Chen
ZCZhenhua Chen
Zhenhua Chen
JWJinhuan Wei
Jinhuan Wei
HYHaohua Yao
Haohua Yao
Original Article Multimodal artificial intelligence model based on CT for differentiating primary renal sarcomas from renal cell carcinomas: a dual-center retrospective study Haishan Lin, Shurong Li, Yuhang Chen, Zhenhua Chen, Jinhuan Wei, Jiumin Liu, Yan Guo, Wei Chen, Huanjun Wang, Junhang Luo, Li Tian, Haohua Yao

30 September 2026 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
JZJing Zhang
Jing Zhang
LGLiwen Gu
Liwen Gu
PDPeixin Dong
Peixin Dong
YHYu Hu
Yu Hu
BLBaomo Liu
Baomo Liu
HYHaohua Yao
Haohua Yao
Background: Extensive-stage small cell lung cancer (ES-SCLC) is a rare yet highly aggressive malignancy with severely limited treatment options. The efficacy of immunotherapy for ES-SCLC remain limited, with only 14% of patients deriving additional benefit from immune checkpoint inhibitors (ICIs), underscoring significant heterogeneity in patient response. This study aimed to develop a model for the accurate prediction of prognosis and therapeutic response to optimize treatment strategies. Methods: 99 and 25 ES-SCLC patients were enrolled as training and independent internal validation cohorts. Baseline CT images, clinical data, and laboratory markers were collected. Prognostic factors were screened via Cox regression. A mediastinal window CT-based deep learning model (MWDL) was developed and combined with Progastrin-releasing peptide (log(ProGRP + 1)) and bone metastasis to establish the novel MWGB-Cox model. Results: ProGRP and bone metastasis were independent prognostic factors with area under the curves (AUCs) of 0.705 and 0.666 respectively for predicting 1-year OS. Among the pure deep learning models, the MWDL model achieved better performance with a mean AUC of 0.813 than the deep learning model based on lung window CT images (LWDL, AUC 0.756). Whereas the multimodal MWGB-Cox model not only achieved the highest AUC (0.902) for 1-year OS prediction, but also effectively overcame the limitation of insufficient sensitivity. The predictive performance of the MWGB-Cox model was further validated in the independent internal validation cohort. Conclusions: This novel, simple, and cost-effective multimodal MWGB-Cox model integrating CT-based deep learning, log(ProGRP + 1), and bone metastasis could robustly predict 1-year OS of ES-SCLC patients receiving first-line immunotherapy, providing a reliable tool for clinical decision-making. Significance: By integrating CT-based deep learning, log(ProGRP + 1) levels, and bone metastasis, the novel multimodal model achieved the highest predictive AUC (0.902) with improved sensitivity, serving as a simple, cost-effective tool for clinical decision-making.